Webinare

NGS-based MRD Testing for Acute Lymphoblastic Leukemia

8 Nov 2022

Tuesday, 11/15/2022
7.00 - 8.00 pm CET

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells, MRD, LymphoTrack®

Sample collection and concentration methods

3 Nov 2022

-- impact on wastewater-based surveillance for multi-pathogen panels
Donnerstag, 10.11.2022 - 18.00 Uhr

Tags: HiSS Diagnostics Solution, Laboratory Developed Tests, Nanotrap, Anreicherung, SARS CoV-2, Abwassertestung, CeresNanosciences, STRECK, Microbiome Particles

Limit of Detection in Liquid Biopsy Assays

10 Oct 2022

on demand

Tags: LGC Clinical Diagnostics, Liquid Biopsy, Reference materials, LoD, Nachweisgrenze, Sensitivität, Seraseq, Seracare, Referenzmaterial

Methylated DNA Biomarkers Detected in Plasma

24 Aug 2022

for Early Cancer Screening and Diagnostics

Tags: LGC Clinical Diagnostics, Immuno-Oncology, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling, Biomarker, Oncology

Enrichment and Testing of viruses and bacteria from wastewater samples

8 Aug 2022

Dr. Andreas Eckelt
on demand

Tags: HiSS Diagnostics Solution, Laboratory Developed Tests, Nanotrap, Anreicherung, SARS CoV-2, Abwassertestung

Next-Generation Sequencing of Immunoglobulin Genes in Lymphoid Malignancies

5 May 2022

Identify genes targeted for clonality assessment in B-cell malignancies
Compare sequencing techniques used for immunoglobulin genes
Describe pre-analytical variables that impact immunoglobulin sequencing
Contrast clonality analysis by next-generation sequencing to traditional non-sequencing methods

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells

Innovation in 3D cell culture: creating a customizable microenvironment to replicate in vivo properties of tissues

30 Mar 2022

on demand webinar

Tags: Cell Guidance Systems, 3D cellculture , physiologically-relevant microenvironment , webinar

IVDR compliant use of LDTs in the laboratory

8 Mar 2022

The IVDR comes into effect on 5/25/2022 and provides new rules for homegrown tests (homebrew/LDTs)
Dr. Andreas Eckelt (IVDRconsulting)

Tags: LGC Clinical Diagnostics, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Oncology, NIPT, NGS, CE-IVD, IVDR, DNA Diagnostics, HiSS Diagnostics Solution, LDT, Laboratory Developed Tests

Understanding and Clarifying the Complexities of HRD Measurements in Cancer

23 Feb 2022

• Ravindra Kolhe, MD, PhD • David Fabrizio, PhD • John Jiang, PhD • Yves Konigshofer, PhD
• available On Demand at genomeweb

Tags: LGC Clinical Diagnostics, Immuno-Oncology, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling, HRD, Biomarker, ADP-Ribose, PARPi, Oncology

Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing

17 Feb 2022

• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)

Tags: Invivoscribe, Leukemia , Multiple Myeloma, Morbus Kahler , Leukämie, ALL , Akute Lymphatische Leukämie, MRD, Messbare (minimale) Resterkrankung (MRD), Minimal Residual Disease (MRD)

The use of Seraseq® Oncology controls & NGS validation challenges

7 Feb 2022

Video recording of the lecture:
- Tumor Profiling - Liquid Biopsy -Immuno-Oncology

Tags: LGC Clinical Diagnostics, Immuno-Oncology, Liquid Biopsy, Reference Materials, LoD, Nachweisgrenze, Sensitivität, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling

Review of Guidelines for Interpreting Somatic Hypermutation Status

26 Jan 2022

in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing

Tags: CLL, SHM status , chronic lymphocytic leukemia, somatic hypermutation , next-generation sequencing , NGS, IVS, Invivoscribe